NCT06456086View on ClinicalTrials.gov

Effect of Epstein-Barr Virus on Macrophage M2/M1 Migration and EphA2 Expression in Adverse Drug Reactions

Active, not recruitingOBSERVATIONAL

Enrollment

27

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

March 31, 2024

Study Completion Date

October 31, 2024

Conditions

Adverse Drug Reactions

Interventions

BIOLOGICAL

stimulation with EB virus

stimulation with EB virus

Trial Locations (1)

650000

Tang Junting, Kunming

All Listed Sponsors

lead

First Affiliated Hospital of Kunming Medical University

OTHER